文献速递前列腺癌

卫生专业人员随访研究中规律长期使用复合维生素与总体及侵袭性前列腺癌风险

Regular, Long-Duration Multivitamin Use and Risk of Overall and Aggressive Prostate Cancer in the Health Professionals Follow-Up Study.
PubMed 文献 · J Urol · 2022-05-06

研究纳入卫生专业人员随访研究48,137名男性,1986年至2017年随访,评估复合维生素使用频率与时长和前列腺癌风险的关系。中位随访30.7年,记录7,108例前列腺癌(564例晚期、1,065例致死性)。与从未使用者相比,每周≥10片或使用≥15年与晚期或致死性前列腺癌风险无显著关联。

要点

  • 48,137名男性随访至2017年,记录7,108例前列腺癌,含564例晚期和1,065例致死性。
  • 每周≥10片复合维生素者晚期前列腺癌HR 1.14(95%CI 0.77-1.70),致死性HR 1.07(95%CI 0.80-1.44)。
  • 使用≥15年者晚期前列腺癌HR 1.10(95%CI 0.80-1.50),致死性HR 1.04(95%CI 0.83-1.31)。

核心结论

  • 在一般营养良好的老年男性中,规律或长期使用复合维生素与总体或侵袭性前列腺癌风险升高或降低均无关。

研究设计与样本

  • 卫生专业人员随访研究队列,纳入48,137名男性,1986年至2017年随访,复合维生素使用及频率在基线自报并每两年更新。
  • 采用Cox比例风险模型估计多变量风险比(HR)和95%置信区间(CI)。

主要发现

  • 无前列腺癌诊断或死亡者的中位随访时间为30.7年,记录7,108例新发前列腺癌,其中564例晚期、1,065例致死性。
  • 与从未使用者相比,每周使用复合维生素≥10片者晚期前列腺癌HR 1.14(95%CI 0.77-1.70,Ptrend=0.46),致死性前列腺癌HR 1.07(95%CI 0.80-1.44,Ptrend=0.59)。
  • 与从未使用者相比,使用复合维生素≥15年者晚期前列腺癌HR 1.10(95%CI 0.80-1.50,Ptrend=0.46),致死性前列腺癌HR 1.04(95%CI 0.83-1.31,Ptrend=0.13)。
  • 总体而言,复合维生素使用与前列腺癌风险呈无效关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Multivitamin supplement is commonly used among older adults in the United States. Evidence on multivitamin use and prostate cancer risk is limited, and some suggested potential risk for clinically important subtypes of cancer. MATERIALS AND METHODS: A total of 48,137 men from the Health Professionals Follow-up Study were followed from 1986 to 2017. Multivitamin use and frequency were self-reported at baseline and updated biennially. Clinical features of prostate cancer included advanced, lethal and high-grade outcomes. Cox proportional hazards models were used to estimate multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) of multivitamin use and incidence of prostate cancer. RESULTS: The median followup for men without prostate cancer diagnosis or death was 30.7 years. We documented 7,108 incident prostate cancer cases including 564 advanced and 1,065 lethal. Overall, we observed a null association between multivitamin use and risk of prostate cancer. Compared to never-users, men who used multivitamin 10 or more tablets per week had similar risk of advanced (HR: 1.14, 95% CI: 0.77-1.70, Ptrend=0.46) or lethal (HR: 1.07, 95% CI: 0.80-1.44, Ptrend=0.59) prostate cancer, and multivitamin use of 15 years or more was not associated with risk of advanced (HR: 1.10, 95% CI: 0.80-1.50, Ptrend=0.46) or lethal (HR: 1.04, 95% CI: 0.83-1.31, Ptrend=0.13) prostate cancer. CONCLUSIONS: Regular or long-duration multivitamin use among older, generally well-nourished men was not associated with either increased or lower risk of overall or aggressive prostate cancer.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Song M, Mucci LA, et al. Regular, Long-Duration Multivitamin Use and Risk of Overall and Aggressive Prostate Cancer in the Health Professionals Follow-Up Study. J Urol. 2022. PMID: 35522215. doi:10.1097/JU.0000000000002735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。